Drug Shortage Report for MEZAVANT
Report ID | 103353 |
Drug Identification Number | 02297558 |
Brand name | MEZAVANT |
Common or Proper name | Mesalamine delayed- and extended-release tablets |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | MESALAZINE |
Strength(s) | 1.2G |
Dosage form(s) | TABLET (DELAYED AND EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 120 tablets / bottle |
ATC code | A07EC |
ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-01-15 |
Actual start date | 2020-01-15 |
Estimated end date | 2020-08-20 |
Actual end date | 2020-08-21 |
Shortage status | Resolved |
Updated date | 2020-08-22 |
Company comments | Constrained supply with product allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2020-08-22 | English | Compare |
v16 | 2020-08-21 | French | Compare |
v15 | 2020-08-21 | English | Compare |
v14 | 2020-07-30 | French | Compare |
v13 | 2020-07-30 | English | Compare |
v12 | 2020-04-28 | French | Compare |
v11 | 2020-04-28 | English | Compare |
v10 | 2020-04-28 | French | Compare |
v9 | 2020-04-28 | English | Compare |
v8 | 2020-01-16 | English | Compare |
v7 | 2020-01-15 | French | Compare |
v6 | 2020-01-15 | English | Compare |
v5 | 2020-01-15 | French | Compare |
v4 | 2020-01-15 | English | Compare |
v3 | 2020-01-15 | French | Compare |
v2 | 2020-01-15 | English | Compare |
v1 | 2020-01-15 | English | Compare |
Showing 1 to 17 of 17